d , Immunoblot analysis of FSP1, ACSL4, p53, p21 and VCP expression in p53 (also known as TP53) wild-type and p53 -knockout (CRISPRCAS9-modified) HT1080 cell lines treated with the MDM2 ( MDM2 proto-oncogene) inhibitor Nutlin3 or the cytostatic compound doxorubicin (Doxo)
investigated whether or not local GLP-1 production in the intestine could differentiate intestinal progenitor cells into insulin-producing cells
Yeah, so I had a bit of a search around for this and theres not this really not much detailed about what the long-term effects of the use of GLP-1 receptor agonists is for the lay population or even for diabetics
Be aware of safety issues and long-term unknowns
What is the downside of BPC 157
Brand-name medications (Ozempic, Wegovy) run $900$1,400/month without insurance